Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TScan Therapeutics (TCRX) Preferred Shares Issued (2021)

Historic Preferred Shares Issued for TScan Therapeutics (TCRX) over the last 1 years, with Q1 2021 value amounting to $99.7 million.

  • TScan Therapeutics' Preferred Shares Issued changed N/A to $99.7 million in Q1 2021 from the same period last year, while for Dec 2021 it was $99.7 million, marking a year-over-year change of. This contributed to the annual value of $99.7 million for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q1 2021, TScan Therapeutics' Preferred Shares Issued is $99.7 million.
  • TScan Therapeutics' 5-year Preferred Shares Issued high stood at $99.7 million for Q1 2021, and its period low was $99.7 million during Q1 2021.